In addition, ceruloplasmin has been shown to predict cognitive decline and brain atrophy in people with underlying Aβ pathology [91] when evaluated in the CSF or when measuring ceruloplasmin specific activity in serum [90]. This evidence concerns the gene CP and Brain atrophy.